US Patent Issued to GC Cell on Aug. 26 for "Method for culturing cord blood-derived natural killer cells using transformed T-cells" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,372, issued on Aug. 26, was assigned to GC Cell Corp. (Gyeonggi-do Republic of, South Korea).

"Method for culturing cord blood-derived natural killer cells using transformed T-cells" was invented by Yusun Kim (Yongin-si, South Korea), Eun Ji Kim (Yongin-si, South Korea), Gyeong-Min Park (Yongin-si, South Korea), Bitna Yang (Yongin-si, South Korea), Bokyung Min (Yongin-si, South Korea), Sungyoo Cho (Yongin-si, South Korea) and Yu Kyeong Hwang (Yongin-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for culturing cord blood-derived natural killer cells using transformed T cells. The method of the...